Follow
WEI ZHAO
WEI ZHAO
Postdoctoral fellow of Division of Cancer Epidemiology and Genetics, National Cancer Institute
Verified email at nih.gov
Title
Cited by
Cited by
Year
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
109552012
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
63422013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
15122014
PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness
J Shen, W Zhao, Z Ju, L Wang, Y Peng, M Labrie, TA Yap, GB Mills, ...
Cancer research 79 (2), 311-319, 2019
4622019
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
J Shen, Z Ju, W Zhao, L Wang, Y Peng, Z Ge, ZD Nagel, J Zou, C Wang, ...
Nature medicine 24 (5), 556-562, 2018
4152018
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
W Zhao, X He, KA Hoadley, JS Parker, DN Hayes, CM Perou
BMC genomics 15, 1-11, 2014
3482014
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
2542012
BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency
C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ...
Cancer cell 33 (3), 401-416. e8, 2018
2392018
Characterization of human cancer cell lines by reverse-phase protein arrays
J Li, W Zhao, R Akbani, W Liu, Z Ju, S Ling, CP Vellano, P Roebuck, Q Yu, ...
Cancer cell 31 (2), 225-239, 2017
2062017
Breast cancer quantitative proteome and proteogenomic landscape
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1600, 2019
1662019
Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer
K Xu, J Usary, PC Kousis, A Prat, DY Wang, JR Adams, W Wang, AJ Loch, ...
Cancer cell 21 (5), 626-641, 2012
1362012
Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases
KA Hoadley, MB Siegel, KL Kanchi, CA Miller, L Ding, W Zhao, X He, ...
PLoS medicine 13 (12), e1002174, 2016
1222016
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19, 1-18, 2017
1022017
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni
Nature Reviews Genetics 18 (7), 395-410, 2017
982017
Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas
J Li, R Akbani, W Zhao, Y Lu, JN Weinstein, GB Mills, H Liang
Cancer research 77 (21), e51-e54, 2017
962017
Genomic and evolutionary classification of lung cancer in never smokers
T Zhang, P Joubert, N Ansari-Pour, W Zhao, PH Hoang, R Lokanga, ...
Nature genetics 53 (9), 1348-1359, 2021
942021
Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction
Y Sun, C Li, L Jin, P Gao, W Zhao, W Ma, M Tan, W Wu, S Duan, Y Shan, ...
European radiology 30, 3650-3659, 2020
932020
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
X Hua, W Zhao, AC Pesatori, D Consonni, NE Caporaso, T Zhang, B Zhu, ...
Nature communications 11 (1), 2459, 2020
882020
Predicting drug responsiveness in human cancers using genetically engineered mice
J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ...
Clinical Cancer Research 19 (17), 4889-4899, 2013
852013
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
L Wang, L Yang, C Wang, W Zhao, Z Ju, W Zhang, J Shen, Y Peng, C An, ...
The Journal of clinical investigation 130 (11), 5951-5966, 2020
772020
The system can't perform the operation now. Try again later.
Articles 1–20